Skip to content

Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

Colorectal Cancer Screening Intervention for Family Members of Colorectal Cancer Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00582829
Enrollment
213
Registered
2007-12-28
Start date
2003-06-30
Completion date
2008-05-31
Last updated
2008-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Colorectal, Intervention, Screening

Keywords

Colorectal, Cancer, Screening, Intervention, Family

Brief summary

This proposed study will use previous study results to guide the development and evaluation of interventions to improve CRC screening acceptance. The proposed study will evaluate the impact of three interventions to promote CRC screening among siblings in this increased-risk group, who are not currently compliant with CRC screening guidelines: 1) a generic print intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored telephone counseling intervention.

Detailed description

First-degree relatives of individuals with CRC are at increased-risk of developing colorectal cancer (CRC). For these increased-risk individuals current guidelines recommend initiating CRC screening a decade earlier than for those at average-risk for CRC; thus, starting at age 40, or 10 years younger than the age at which the affected relative was diagnosed with CRC. In our prior study of 504 at-risk siblings of patients with a history of CRC, diagnosed at age less than 56, we found that approximately 44% of these siblings were not compliant with CRC screening guidelines. Guided by the Transtheoretical, Health Belief and Dual Process models, our prior study identified key attitudinal and non-attitudinal predictors of screening behaviors and intentions. This proposed study will use these results to guide the development and evaluation of interventions to improve CRC screening acceptance. The proposed study will evaluate the impact of three interventions to promote CRC screening among siblings in this increased-risk group, who are not currently compliant with CRC screening guidelines: 1) a generic print intervention; 2) a tailored print intervention, and; 3) a tailored print plus tailored telephone counseling intervention. Siblings in the generic print condition will receive a pamphlet about colorectal cancer screening published by the Center for Disease Control. Siblings in the tailored print and telephone counseling conditions will receive messages tailored specifically to their responses on targeted attitudinal and non-attitudinal measures. Five hundred twenty four siblings meeting eligibility criteria will be randomly assigned to one of the three conditions after a baseline interview assessing CRC screening behaviors and attitudes, and it is anticipated that 427 siblings will complete the study. For siblings in the tailored conditions, baseline information will be utilized to design the tailored messages. After receiving the intervention information, participants will be interviewed again six months later regarding CRC screening behaviors and attitudes to assess the impact of the intervention.

Interventions

OTHERGeneric Print Intervention

Generic Print Intervention: The generic print intervention will consist of the pamphlet, Colorectal Cancer Screening Saves Lives published by the Center for Disease Control that will be mailed to the participant.

OTHERTailored Print Intervention

Tailored Print Intervention: The tailored print intervention will consist of a cover letter detailing the participant's stage of readiness along with a color pamphlet with information personally tailored for the individual participant.

OTHERTailored print plus tailored phone intervention

Tailored print plus tailored phone intervention: The tailored print plus tailored telephone intervention will consist of a phone counseling session and the tailored print information described above. The tailored print material will serve as a guide during the telephone counseling contact and a reinforcement of the information.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Fox Chase Cancer Center
CollaboratorOTHER
Icahn School of Medicine at Mount Sinai
CollaboratorOTHER
Lombardi Comprehensive Cancer Center
CollaboratorOTHER
Micromass Communications, Cary, NC
CollaboratorUNKNOWN
University of Pennsylvania
CollaboratorOTHER
Christiana Care Health Services
CollaboratorOTHER
Pinnacle Health Regional Cancer Center, Harrisburg, PA
CollaboratorUNKNOWN
Temple University
CollaboratorOTHER
St. Mary Regional Cancer Center, Langhorne, PA
CollaboratorUNKNOWN
South Jersey Regional Cancer Center, Bridgton, New Jersey
CollaboratorUNKNOWN
Hunterdon Cancer Center
CollaboratorUNKNOWN
Northeast Regional Cancer Institute
CollaboratorOTHER
Virtua Memorial Hospital and Virtua West
CollaboratorUNKNOWN
Jersey Hospital
CollaboratorUNKNOWN
Rutgers Cancer Institute of New Jersey
CollaboratorOTHER
Massachusetts General Hospital
CollaboratorOTHER
Main Line Health
CollaboratorOTHER
Roswell Park Cancer Institute
CollaboratorOTHER
HematologyOncology
CollaboratorUNKNOWN
Associates of Central New York
CollaboratorUNKNOWN
Augusta University
CollaboratorOTHER
Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* How old is the participant? (≥ 18 years) * Is the participant either: * currently age 40 or above (YES) OR * within 10 years of the age at which the patient/proband was initially diagnosed with CRC (whichever is the younger age) (YES) * Is the participant a full or half biological sibling of the patient/proband? (YES)

Exclusion criteria

* Is the participant currently not compliant with standard CRC screening guidelines? (NO) * Is the participant English speaking? (YES) * Does the participant have a primary language other than English? (NO) * Does the participant have a history of Inflammatory Bowel Disease? (NO) * Does the participant have a history of colorectal cancer of colorectal polyp? (NO) * Does the participant have a history of hereditary colorectal cancer syndrome? (Familial Adenomatous Polyposis or Hereditary Nonpolyposis Colorectal Cancer) (NO)

Design outcomes

Primary

MeasureTime frame
Phone follow-up interview. Participants will be contacted by study assistant and the survey administered.6 months after baseling

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026